problems with glp-1 drugs Comparing Ozempic, Wegovy and Other The GLP-1 Agonists and Obesity:

Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.

GLP-1 patches for weight loss have made the scenebut a leading MD warns you they aren't the same as the more familiar prescriptions.

Order easily online!

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

Here's what clinicians should know.

Gastrointestinal side effects are a little more common in the oral version than in the injectables